Pointe Capital Management LLC Sells 218 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Pointe Capital Management LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,538 shares of the healthcare conglomerate’s stock after selling 218 shares during the period. Pointe Capital Management LLC’s holdings in UnitedHealth Group were worth $810,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. TCG Advisory Services LLC grew its stake in UnitedHealth Group by 60.5% during the fourth quarter. TCG Advisory Services LLC now owns 33,234 shares of the healthcare conglomerate’s stock worth $17,497,000 after buying an additional 12,525 shares during the last quarter. Forte Capital LLC ADV increased its holdings in UnitedHealth Group by 2.0% during the 4th quarter. Forte Capital LLC ADV now owns 2,203 shares of the healthcare conglomerate’s stock valued at $1,160,000 after purchasing an additional 44 shares in the last quarter. Red Cedar Investment Management LLC boosted its stake in UnitedHealth Group by 4.9% in the fourth quarter. Red Cedar Investment Management LLC now owns 6,573 shares of the healthcare conglomerate’s stock worth $3,460,000 after purchasing an additional 306 shares in the last quarter. Charles Carroll Financial Partners LLC increased its stake in shares of UnitedHealth Group by 4.6% in the fourth quarter. Charles Carroll Financial Partners LLC now owns 5,706 shares of the healthcare conglomerate’s stock valued at $3,004,000 after buying an additional 250 shares in the last quarter. Finally, Royal Fund Management LLC lifted its position in UnitedHealth Group by 5.3% during the 4th quarter. Royal Fund Management LLC now owns 5,458 shares of the healthcare conglomerate’s stock worth $2,874,000 after buying an additional 273 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on UNH shares. Piper Sandler upped their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research note on Thursday, April 4th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Truist Financial restated a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Finally, Stephens reissued an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH traded down $0.52 during mid-day trading on Friday, hitting $492.45. 2,487,811 shares of the company’s stock were exchanged, compared to its average volume of 5,130,659. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a 50-day simple moving average of $482.32 and a 200 day simple moving average of $512.76. The company has a market cap of $453.09 billion, a PE ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same period last year, the business earned $6.26 earnings per share. The firm’s revenue was up 8.6% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.